| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |